BELDEN INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BELDEN INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.72B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.46B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.51B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.61B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.30B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $1.75B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $549.69M | Feb 11, 2020 |
| FY2019 | Sep 29, 2019 | $533.10M | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $548.35M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $500.14M | Feb 11, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $655.39M | Feb 20, 2019 |
| FY2018 | Sep 30, 2018 | $655.77M | Feb 20, 2019 |
| FY2018 | Jul 1, 2018 | $668.64M | Feb 20, 2019 |
| FY2018 | Apr 1, 2018 | $605.57M | Feb 20, 2019 |
| FY2018 | Dec 31, 2017 | $604.88M | Feb 20, 2019 |
| FY2018 | Oct 1, 2017 | $621.75M | Feb 20, 2019 |
| FY2018 | Jul 2, 2017 | $610.63M | Feb 20, 2019 |
| FY2018 | Apr 2, 2017 | $551.38M | Feb 20, 2019 |
| FY2018 | Dec 31, 2016 | $2.36B | Feb 20, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $922.22M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $954.97M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $916.29M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $771.84M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $575.62M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $202.77M | Feb 11, 2020 |
| FY2019 | Sep 29, 2019 | $198.81M | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $205.07M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $186.86M | Feb 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $237.52M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $198.43M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $242.76M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $254.66M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $63.93M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | ($55.16M) | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | ($147.41M) | Feb 11, 2020 |
| FY2019 | Sep 29, 2019 | ($297.01M) | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $42.20M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $25.20M | Feb 11, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $315.69M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $266.46M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $317.52M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $363.33M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $263.68M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $150.11M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $43.40M | Feb 11, 2020 |
| FY2019 | Sep 29, 2019 | $57.54M | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $58.78M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $47.49M | Feb 11, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $128.76M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $112.37M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $116.43M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $104.35M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $90.23M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $73.02M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $94.36M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $91.55M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $88.75M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $140.52M | Feb 20, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $533.37M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $494.60M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $492.70M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $448.64M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $378.03M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $323.45M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $417.33M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $411.35M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $389.74M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $486.40M | Feb 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $354.86M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $352.08M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $319.64M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $281.30M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $272.06M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $173.36M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $276.89M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $289.22M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $255.30M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $314.79M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.17M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $129.10M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $116.73M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $105.09M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $90.98M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $90.22M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $110.00M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $97.85M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $64.26M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $53.97M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.54B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.33B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $3.24B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $3.16B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $3.42B | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $3.14B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $3.41B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $3.78B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $3.84B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $3.81B | Feb 20, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.26B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.17B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.14B | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $955.29M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $750.58M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $959.85M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.39B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $1.43B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $1.46B | Feb 13, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $1.02B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $907.33M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $862.25M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $821.45M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $789.74M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.24B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $1.21B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.21B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $1.39B | Feb 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.41B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $985.81M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $751.52M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $505.72M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $450.88M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $518.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $922.00M | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $833.61M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $783.81M | Feb 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $389.89M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $370.30M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $597.04M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $687.68M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $641.56M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $500.67M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $407.48M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $407.45M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $541.35M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $848.12M | Feb 20, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $1.62B | Feb 17, 2017 |
| FY2016 | Dec 31, 2015 | $1.73B | Feb 17, 2017 |
| FY2015 | Dec 31, 2014 | $1.77B | Feb 25, 2016 |
| FY2014 | Dec 31, 2013 | $1.37B | Feb 23, 2015 |
| FY2013 | Dec 31, 2012 | $1.15B | Feb 27, 2014 |
| FY2012 | Dec 31, 2011 | $550.93M | Feb 28, 2013 |
| FY2011 | Dec 31, 2010 | $551.16M | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | (3) | Feb 11, 2020 |
| FY2019 | Sep 29, 2019 | (6) | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 11, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | (3) | Feb 11, 2020 |
| FY2019 | Sep 29, 2019 | (6) | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 11, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 38.95M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 40.21M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | 41.13M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 42.83M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | 44.98M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 44.64M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | 45.46M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 39.40M | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | 42.02M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 42.18M | Feb 13, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.97M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $8.20M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $8.50M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $8.95M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $9.06M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $9.03M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $34.44M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $43.17M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $43.38M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $16.08M | Feb 20, 2019 |